As of Jan 17
| -0.0398 / -5.45%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +769.56% increase from the last price of 0.69.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.